DOSSIER · UPDATED 18 JUN 2026

Tempest Therapeutics

Tempest Therapeutics Inc. operates as a development-stage biotechnology company. The Company focuses on targeted and immune-eediated cancer therapies that modulate anti-tumor immunity pathways. Tempest Therapeutics serves customers…

ovascience.com ↗Claim this profile

Founded: 2011
Headcount: 53
Open roles: 0
Last raised: Post Ipo Equity · $2M

SECTION I · THE BRIEF

Inside Tempest Therapeutics

Brief #16432Updated 18 JUN 2026ANN ARBORMEDICAL ORGANIZATIONSPOST IPO EQUITY

Employbl Dossier

Tempest Therapeutics

Tempest Therapeutics Inc. operates as a development-stage biotechnology company. The Company focuses on targeted and immune-eediated cancer therapies that modulate anti-tumor immunity pathways. Tempest Therapeutics…

Founded: 2011
Headcount: 53
Open roles: 0
Last raised: Post Ipo Equity · $2M

Section II · Premium ProfileMembers only

01Engineering interview process at Tempest TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Tempest Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

David Sinclair

Christoph Westphal

Michelle Dipp

OPEN ROLES

Hiring at Tempest Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $614,272,832

Tempest Therapeutics' Investors

General Catalyst

Tempest Therapeutics Funding Rounds

Post Ipo Equity
$2,000,000
Mar 23, 2026
Post Ipo Equity
$8,350,000
Nov 25, 2025
Post Ipo Equity
$4,600,000
Jun 11, 2025
Post Ipo Equity
$15,000,000
Apr 27, 2022
Post Ipo Equity
$50,000,000
Mar 1, 2020
Post Ipo Equity
$25,000,000
Dec 4, 2019
Series Unknown
$30,000,000
Aug 9, 2018
Series B
$70,000,000
Mar 28, 2018
Post Ipo Equity
$53,800,000
Jun 1, 2016
Series B
$62,000,000
Jan 5, 2016
Post Ipo Equity
$132,000,000
Jan 12, 2015
Post Ipo Equity
$50,000,000
Mar 4, 2014
IPO
Unknown
Apr 30, 2013
Post Ipo Equity
$34,999,920
Mar 28, 2013
Private Equity
$8,522,872
Feb 26, 2013
Series C
$4,000,000
Aug 7, 2012
Series A
$16,000,000
Aug 3, 2012
Series B
$37,000,000
Apr 3, 2012
Series A
$6,000,000
Oct 11, 2011
Series A
$5,000,000
Oct 5, 2011

Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections Tempest Therapeutics is a part of. Click on the collection name to view similar companies.

Tempest Therapeutics' Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

Tempest Therapeutics' Investors

General Catalyst

LOCATIONS

Where they work

Tempest Therapeutics Headquarters Location

301 N. Main St Suite 100, Ann Arbor, MI, 48104

Loading map…